RecallRadar

FDA Drug recall D-0883-2017

Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kur…

On 2017-06-14 the FDA classified a Class II recall of Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kur… by Dr Reddy S Laboratories, citing failed Dissolution Specifications: out of specification results observed for low dissolution.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0883-2017
ClassificationClass II
Statusterminated
Initiated2017-05-22
Published2017-06-14
Last updated2026-09-13 11:51 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-135-81

Reason

Failed Dissolution Specifications: out of specification results observed for low dissolution.

Identifiers

ndc55111-135-79
ndc55111-135-81
ndc55111-136-79
ndc55111-136-81
ndc55111-137-79
ndc55111-137-81
ndc55111-113-79
ndc55111-113-81
ndc55111-113-78
code_infoLot #: KB50471, Exp 06/17; KB50710, KB50710A, Exp 08/17; KB60198, Exp 02/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0883-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.